BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sridhar SN, Ginson G, Venkataramana Reddy PO, Tantak MP, Kumar D, Paul AT. Synthesis, evaluation and molecular modelling studies of 2-(carbazol-3-yl)-2-oxoacetamide analogues as a new class of potential pancreatic lipase inhibitors. Bioorg Med Chem 2017;25:609-20. [PMID: 27908755 DOI: 10.1016/j.bmc.2016.11.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Sridhar SNC, George G, Verma A, Paul AT. Natural Products-Based Pancreatic Lipase Inhibitors for Obesity Treatment. In: Akhtar MS, Swamy MK, Sinniah UR, editors. Natural Bio-active Compounds. Singapore: Springer; 2019. pp. 149-91. [DOI: 10.1007/978-981-13-7154-7_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 George G, S˙n˙c˙ S, Paul AT. Investigation of synergistic potential of green tea polyphenols and orlistat combinations using pancreatic lipase assay-based synergy directed fractionation strategy. South African Journal of Botany 2020;135:50-7. [DOI: 10.1016/j.sajb.2020.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Chaitanya M, Reddy PV, Nikhil K, Kumar A, Shah K, Kumar D. Synthesis and anticancer activity studies of indolylisoxazoline analogues. Bioorganic & Medicinal Chemistry Letters 2018;28:2842-5. [DOI: 10.1016/j.bmcl.2018.07.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hamdan II, Kasabri VN, Al-hiari YM, El-sabawi D, Zalloum H. Pancreatic lipase inhibitory activity of selected pharmaceutical agents. Acta Pharmaceutica 2019;69:1-16. [DOI: 10.2478/acph-2019-0010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 S.n.c. S, Sengupta P, Paul AT. Development and validation of a new HPTLC method for quantification of conophylline in Tabernaemontana divaricata samples obtained from different seasons and extraction techniques: Insights into variation of pancreatic lipase inhibitory activity. Industrial Crops and Products 2018;111:462-70. [DOI: 10.1016/j.indcrop.2017.11.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 George G, Auti PS, Paul AT. Design, synthesis and biological evaluation of N-substituted indole-thiazolidinedione analogues as potential pancreatic lipase inhibitors. Chem Biol Drug Des 2021;98:49-59. [PMID: 33864339 DOI: 10.1111/cbdd.13846] [Reference Citation Analysis]
7 Katoch M, Paul A, Singh G, Sridhar SNC. Fungal endophytes associated with Viola odorata Linn. as bioresource for pancreatic lipase inhibitors. BMC Complement Altern Med 2017;17:385. [PMID: 28774309 DOI: 10.1186/s12906-017-1893-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
8 S N C S, Sengupta P, Palawat S, P S D, George G, Paul AT. Synthesis, molecular modelling, in vitro and in vivo evaluation of conophylline inspired novel benzyloxy substituted indole glyoxylamides as potent pancreatic lipase inhibitors. J Biomol Struct Dyn 2021;:1-13. [PMID: 34032197 DOI: 10.1080/07391102.2021.1930168] [Reference Citation Analysis]
9 Patel OP, Arun A, Singh PK, Saini D, Karade SS, Chourasia MK, Konwar R, Yadav PP. Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells. European Journal of Medicinal Chemistry 2019;167:226-44. [DOI: 10.1016/j.ejmech.2019.02.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chen J, Wu H, Gui Q, Han X, Wu Y, Du K, Cao Z, Lin Y, He W. Electrochemical Synthesis of α-Ketoamides under Catalyst-, Oxidant-, and Electrolyte-Free Conditions. Org Lett 2020;22:2206-9. [DOI: 10.1021/acs.orglett.0c00387] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
11 Zengin G, Bulut G, Mollica A, Haznedaroglu MZ, Dogan A, Aktumsek A. Bioactivities of Achillea phrygia and Bupleurum croceum based on the composition of phenolic compounds: In vitro and in silico approaches. Food Chem Toxicol 2017;107:597-608. [PMID: 28343034 DOI: 10.1016/j.fct.2017.03.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
12 S. N. C. S, Palawat S, Paul AT. Design, synthesis, biological evaluation and molecular modelling studies of conophylline inspired novel indolyl oxoacetamides as potent pancreatic lipase inhibitors. New J Chem 2020;44:12355-69. [DOI: 10.1039/d0nj02622k] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 S.n.c. S, Bhurta D, Kantiwal D, George G, Monga V, Paul AT. Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors. Bioorganic & Medicinal Chemistry Letters 2017;27:3749-54. [DOI: 10.1016/j.bmcl.2017.06.069] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
14 Ma J, Cui X, Xu J, Tan Y, Wang Y, Wang X, Li Y. One-Pot Synthesis of α-Ketoamides from α-Keto Acids and Amines Using Ynamides as Coupling Reagents. J Org Chem 2022. [PMID: 35029390 DOI: 10.1021/acs.joc.1c02453] [Reference Citation Analysis]
15 Kumar A, Chauhan S. Pancreatic lipase inhibitors: The road voyaged and successes. Life Sci 2021;271:119115. [PMID: 33515565 DOI: 10.1016/j.lfs.2021.119115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sridhar SNC, Palawat S, Paul AT. Design, synthesis, biological evaluation and molecular modelling studies of indole glyoxylamides as a new class of potential pancreatic lipase inhibitors. Bioorg Chem 2019;85:373-81. [PMID: 30658237 DOI: 10.1016/j.bioorg.2019.01.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
17 George G, P. S D, Paul AT. Development and validation of a new HPTLC-HRMS method for the quantification of a potent pancreatic lipase inhibitory lead Echitamine from Alstonia scholaris. Natural Product Research. [DOI: 10.1080/14786419.2019.1705817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Chauhan D, George G, Sridhar SNC, Bhatia R, Paul AT, Monga V. Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors. Arch Pharm (Weinheim) 2019;352:e1900029. [PMID: 31407389 DOI: 10.1002/ardp.201900029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
19 Kumar A, Chauhan S. Use of Simplified Molecular Input Line Entry System and molecular graph based descriptors in prediction and design of pancreatic lipase inhibitors. Future Medicinal Chemistry 2018;10:1603-22. [DOI: 10.4155/fmc-2018-0024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
20 Robello M, Barresi E, Baglini E, Salerno S, Taliani S, Settimo FD. The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities. J Med Chem 2021;64:3508-45. [PMID: 33764065 DOI: 10.1021/acs.jmedchem.0c01808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Sridhar SNC, Palawat S, Paul AT. Design, synthesis, evaluation, and molecular modeling studies of indolyl oxoacetamides as potential pancreatic lipase inhibitors. Arch Pharm (Weinheim) 2020;353:e2000048. [PMID: 32484265 DOI: 10.1002/ardp.202000048] [Reference Citation Analysis]
22 S. N. C. S, Mutya S, Paul AT. Bis-indole alkaloids from Tabernaemontana divaricata as potent pancreatic lipase inhibitors: molecular modelling studies and experimental validation. Med Chem Res 2017;26:1268-78. [DOI: 10.1007/s00044-017-1836-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
23 Vo CT, Luu NVH, Nguyen TTH, Nguyen TT, Ho BQ, Nguyen TH, Tran T, Nguyen Q. Screening for pancreatic lipase inhibitors: evaluating assay conditions using p -nitrophenyl palmitate as substrate. All Life 2022;15:13-22. [DOI: 10.1080/26895293.2021.2019131] [Reference Citation Analysis]